XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Treasury Stock, Value
Accumulated Other Comprehensive Loss
Balance at beginning of year (in shares) at Dec. 28, 2019   220,000,000        
Balance at beginning of year at Dec. 28, 2019 $ 3,709 $ 2 $ 2,845 $ 916   $ (54)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense 40   40      
Proceeds from employee share purchase plan (in shares)   1,000,000        
Proceeds from employee stock purchase plan 18   18      
Exercise of stock options (in shares)   0        
Stock Issued During Period, Value, Stock Options Exercised 3   3      
Tax withholding payments for net share-settled equity awards (5)   (5)      
Series A convertible preferred stock dividends (28)     (28)    
Changes in retirement benefit obligations, net of income tax 23         23
Recognition of interest rate swaps (3)         (3)
Adoption of ASU 2016-13 (Note 6) (1)     (1)    
Net income (loss) (226)     (226)    
Balance at end of year at Jan. 02, 2021 3,530 $ 2 2,901 661   (34)
Shares, Outstanding, Ending Balance at Jan. 02, 2021   221,000,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense 48   48      
Proceeds from employee share purchase plan (in shares)   1,000,000        
Proceeds from employee stock purchase plan 20   20      
Vested restricted stock units, net, shares   1,000,000        
Vested restricted stock units, net 0   0      
Stock Issued During Period, Value, Stock Options Exercised 15   15      
Tax withholding payments for net share-settled equity awards (14)   (14)      
Series A convertible preferred stock dividends (43)     (43)    
Changes in retirement benefit obligations, net of income tax 10         10
Recognition of interest rate swaps 5         5
Net income (loss) 164     164    
Balance at end of year at Jan. 01, 2022 3,735 $ 2 2,970 782 $ 0 (19)
Shares, Outstanding, Ending Balance at Jan. 01, 2022   223,000,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense 45   45      
Proceeds from employee share purchase plan (in shares)   0        
Proceeds from employee stock purchase plan 22   22      
Vested restricted stock units, net, shares   1,000,000        
Vested restricted stock units, net $ 0   0      
Exercise of stock options (in shares) 859,031          
Stock Issued During Period, Value, Stock Options Exercised $ 15   15      
Tax withholding payments for net share-settled equity awards (16)   (16)      
Series A convertible preferred stock dividends (37)     (37)    
Changes in retirement benefit obligations, net of income tax (54)         (54)
Recognition of interest rate swaps 0          
Treasury Stock, Value 14       (14)  
Net income (loss) 265     265    
Balance at end of year at Dec. 31, 2022 $ 3,961 $ 2 $ 3,036 $ 1,010 $ (14) $ (73)
Shares, Outstanding, Ending Balance at Dec. 31, 2022   225,000,000